AscellaHealth, a global healthcare and specialty pharmacy solutions company, has been named a 2022 Philadelphia (PHL) Inno Fire Award honoree in the Ablaze category for tech-enabled growth and service in the health care industry. The annual awards recognize 20 organizations and individuals who are setting the innovation scene on fire in the Greater Philadelphia market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220825005042/en/

(Graphic: Business Wire)

“This recognition is a tribute to our staff who dedicate their energy, passion and expertise to helping people with rare diseases and complex medical conditions and other industry stakeholders via our innovative programs and services for enhanced medication access and clinical outcomes,” says Dea Belazi, president and CEO, AscellaHealth. “It humbles us to be recognized by the Philadelphia business community for our work benefiting patients, payers, pharmaceutical manufacturers and providers.”

AscellaHealth has applied a clinical, technology-based service delivery model to access specialty medications, increase clinical outcomes and improve the patient experience. Its customized, a la carte menu program and services to improve access to expensive, specialty pharmaceuticals set the trends for industry.

“Our amazing and dedicated teams deserve the credit for the unprecedented growth of AscellaHealth,” adds Belazi. “This honor is further testimony to their accomplishments.”

During the evaluation period for the 2022 Fire Award, AscellaHealth acquired Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization. Optime Care offers a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders.

“This acquisition has not only rounded out AscellaHealth’s suite of services to support all segments of the industry, including patients, payers, pharmaceutical manufacturers and providers but also contributed to significant staff expansion and year-over-year revenue growth,” concludes Belazi.

About AscellaHealth LLC

AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences manufacturers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Most recently, AscellaHealth has joined with its subsidiaries, Optime Care and Terebellum to form the AscellaHealth Family of Companies. Visit www.AscellaHealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220825005042/en/